Drug Design Development and Therapy,
Год журнала:
2025,
Номер
Volume 19, С. 2005 - 2016
Опубликована: Март 1, 2025
The
quality
of
postoperative
recovery
under
enhanced
after
surgery
protocols
has
always
been
the
focus
anesthesiologists.
It
proven
that
esketamine
application
during
perioperative
period
can
reduce
use
opioid
drugs
and
improve
recovery.
present
study
explored
effect
esketamine-based
opioid-sparing
anesthesia
protocol
on
in
patients
undergoing
elective
urological
surgery.
A
randomized,
double-blind,
controlled
clinical
trial
was
adopted.
Patients
aged
18-65
years,
with
American
Society
Anesthesiologists
physical
status
grades
I-III,
scheduled
for
laparoscopic
partial
nephrectomy
or
unilateral
surgery,
were
randomly
divided
into
OSA
group
control
group.
received
0.25
mg/kg
induction
operation,
maintenance
carried
out
at
a
rate
0.125
mg·kg⁻¹·h⁻¹.
primary
outcome
measure
Quality
Recovery
Scale-15
score
24
hours
operation.
total
significantly
higher
than
groups
operation
(114
[108,
116]
vs
106
[102,
109],
p
<
0.001).
level
better
post-anesthesia
care
unit,
demonstrated
by
shorter
eye-opening
time
(19
[17
20]
22
[18,
22],
=
0.031)
extubation
(20
[20,
23]
25
25],
0.004).
Additionally,
incidence
nausea
vomiting
within
0-48
lower
groups.
early
recovery,
accelerate
rehabilitation
Journal of Anesthesia and Translational Medicine,
Год журнала:
2024,
Номер
3(3), С. 65 - 75
Опубликована: Июль 11, 2024
Ketamine,
a
dissociative
anesthetic,
is
widely
utilized
in
both
human
and
veterinary
anesthesia.
Its
(S)-enantiomer,
esketamine,
similarly
employed
for
anesthesia
analgesia.
The
anesthetic
effects
of
ketamine
esketamine
arise
from
their
antagonism
the
N-methyl-D-aspartate
receptor
(NMDAR).
In
field
psychiatry,
rapid-acting
antidepressant
properties
severe
depression
have
generated
significant
interest,
resulting
its
increased
off-label
usage
United
States
(U.S.).
2019,
nasal
spray
received
approval
use
U.S.
Europe.
However,
concerns
emerged
regarding
potential
adverse
effects,
including
long-term
efficacy,
addiction
risks,
suicide
risk
clinical
settings.
contrast,
arketamine,
(R)-enantiomer
ketamine,
exhibits
superior
longer-lasting
rodent
models
depression,
with
fewer
side
compared
to
esketamine.
Nevertheless,
research
on
efficacy
safety
arketamine
patients
remains
limited.
This
article
provides
concise
exploration
historical
two
enantiomers
while
also
delving
into
future
directions
application
these
fields.
Minerva Anestesiologica,
Год журнала:
2024,
Номер
90(4)
Опубликована: Март 18, 2024
INTRODUCTION:
The
aim
of
this
systemic
review
and
meta-analysis
was
to
assess
the
impact
prophylactic
use
esketamine
on
postoperative
depression
quality
life
in
patients.EVIDENCE
ACQUISITION:
We
searched
for
all
articles
patients
after
surgury
electronic
data
bases,
including
PubMed,
EMBASE,
Cochrane
Central
Register
Controlled
Trials,
Web
Science,
up
June
2023.The
included
studies
compared
using
placebo
through
randomized
controlled
trials.
outcome
measurements
consist
indicators
that
can
reflect
patients'
post
Risk
Bias
tool
Review
Manager
5.4
adopted
risk
bias.EVIDENCE
SYNTHESIS:
study
a
total
11
trials
with
1447
participants.
This
demonstrated
prophylacticuse
alleviated
depressive
symptoms
(standardized
mean
difference
[SMD]:
-0.61;
95%
confidence
interval
[CI]:
-0.96
-0.25;
P=0.0008)
incidence
(relative
[RR]:0.37;95%
0.22
0.62;
P=0.0001),
reducing
occurrence
depression,
anxiety,
chronic
pain.
Additionally,
it
improved
sleep
enhanced
patients.CONCLUSIONS:
Prophylactic
during
preoperative
anesthesia
period
has
shown
significant
benefits
improving
life.
It
effectively
alleviate
pain,
as
well
enhance
quality.
Perioperative Medicine,
Год журнала:
2025,
Номер
14(1)
Опубликована: Фев. 11, 2025
This
study
aims
to
investigate
the
effects
of
remimazolam
on
postoperative
melatonin
secretion,
sleep
rhythm,
and
delirium
(POD)
in
elderly
patients
undergoing
spinal
surgery.
We
selected
120
scheduled
for
elective
surgery
(lumbar
interbody
fusion
via
a
posterior
approach)
under
general
anaesthesia
from
November
2023
January
2024.
They
were
divided
into
2
groups
according
medication,
group
(R
group)
propofol
(P
group),
with
60
each
group.
The
R
received
an
induction
dose
0.2
~
0.3
mg/kg,
followed
by
continuous
infusion
at
0.1–0.2
mg/kg/h
maintenance.
P
1.5
2.0
4–6
Melatonin
cortisol
concentrations
measured
04:00
day
days
1,
2,
3.
Pittsburgh
Sleep
Quality
Index
(PSQI)
resting
visual
analog
scale
(VAS)
pain
scores
recorded
before
surgery,
1
as
well
prior
discharge.
Additionally,
we
documented
extubation
time,
PACU
stay
duration,
total
effective
button
presses
analgesia
pump,
instances
supplemental
analgesia,
occurrence
complications.
Compared
group,
exhibited
significantly
shorter
time
duration
<
0.05).
On
04:00,
higher,
lower,
PSQI
reduced
incidence
POD
disturbance
(POSD)
was
also
lower
Furthermore,
VAS
compared
There
no
statistically
significant
differences
between
two
terms
pump
presses,
rates,
intraoperative
hypotension,
or
incidences
nausea,
vomiting,
dizziness,
respiratory
depression
>
use
has
minimal
impact
secretion
rhythms
patterns,
may
reduce
alleviate
disturbances.
British Journal of Anaesthesia,
Год журнала:
2023,
Номер
131(2), С. 385 - 396
Опубликована: Июнь 10, 2023
Patients
often
experience
severe
pain
after
scoliosis
correction
surgery.
Esketamine
and
dexmedetomidine
each
improves
analgesia
but
can
produce
side-effects.
We
therefore
tested
the
hypothesis
that
a
mini-dose
esketamine-dexmedetomidine
combination
safely
analgesia.Two
hundred
male
female
adults
having
surgery
were
randomised
to
patient-controlled
sufentanil
(4
μg
kg-1
in
normal
saline)
with
either
combined
supplement
(esketamine
0.25
mg
ml-1
1
ml-1)
or
placebo.
The
primary
outcome
was
incidence
of
moderate-to-severe
within
72
h,
defined
as
numeric
rating
scale
(NRS:
0=no
10=worst
pain)
score
≥4
at
any
seven
time
points.
Amongst
secondary
outcomes,
subjective
sleep
quality
assessed
an
NRS
(0=best
sleep)
for
first
five
postoperative
nights.There
199
subjects
included
intention-to-treat
analysis.
Mean
infusion
rates
5.5
h-1
esketamine
0.02
dexmedetomidine.
lower
(65.7%
[65/99])
than
placebo
(86.0%
[86/100];
relative
risk
0.76;
95%
confidence
interval:
0.65-0.90;
P=0.001).
Subjects
given
had
intensity
rest
points
(median
difference
-1
point;
P≤0.005),
movement
six
P≤0.001),
better
5
nights
-2
points;
P<0.001).
Adverse
events
did
not
differ
between
groups.The
improved
surgery.NCT04791059.
BMC Anesthesiology,
Год журнала:
2024,
Номер
24(1)
Опубликована: Фев. 1, 2024
Abstract
Background
Esketamine,
recognized
for
its
analgesic,
sedative,
and
anti-inflammatory
qualities,
is
integral
in
multimodal
analgesia.
However,
the
potential
opioid-sparing
effects
of
intravenous
esketamine,
along
with
impact
on
inflammatory
responses,
cognitive
function
during
laparoscopic
surgery,
remain
unexplored.
Methods
In
this
study,
90
patients
scheduled
cholecystectomy
were
equally
randomized
into
three
groups:
a
normal
saline
control
group
(NS),
low-dose
esketamine
(LS)
high-dose
(HS).
Subsequently,
we
monitored
several
parameters:
hemodynamics,
levels
stress
intraoperative
doses
sufentanil,
remifentanil,
propofol,
24-hour
postoperative
sufentanil
requirements.
We
also
evaluated
alterations
function,
perioperative
indicators,
adverse
reactions
among
groups.
Results
Compared
to
their
5
minutes
prior
anesthesia
(T
0
)
30
post-operation
4
),
NS
exhibited
more
significant
decrease
Mean
Arterial
Pressure
(MAP)
Heart
Rate
(HR)
at
various
time
intervals:
after
skin
incision
1
post-incision
2
conclusion
operation
3
compared
LS
HS
groups(
P
<
0.05).
Furthermore,
greater
increase
adrenaline
(AD),
noradrenaline
(NE),
endothelin
(ET),
C-reactive
protein
(CRP),
tumor
necrosis
factor-alpha
(TNF-α),
interleukin-6
(IL-6)
T
,
so
than
other
two
24
hours
had
significantly
higher
Montreal
Cognitive
Assessment
(MoCA)
scores
those
group(
The
groups
required
lower
surgery
(
0.05),
experienced
shorter
recovery
times,
incidences
nausea,
vomiting,
respiratory
depression
Conclusion
administration
has
been
shown
be
safe,
effective,
dependable
context
gallbladder
surgery.
It
capacity
stabilize
hemodynamic
ameliorate
both
from
hastens
recovery.
it
fosters
restoration
function.
Notably,
when
combined
nalbuphine,
exhibits
effects,
reducing
outcomes.
Trial
registration
trial
registered
China
Clinical
Trials
Registry
Registration
Number:
ChiCTR2300067596.
Retrospectively
(date
registration:
12/01/2023).